JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (9): 71-79.doi: 10.6040/j.issn.1671-7554.0.2015.514

Previous Articles     Next Articles

Serum TK1 for the diagnosis of cancer in Chinese patients: a Meta-analysis

LIU Jingsheng1, LIU Guihua1, DU Kun1, ZHAO Qian2, WENG Shaobo1, ZHAO Xueying1, ZHANG Xizhuang1, JIN Xunbo3   

  1. 1. Department of Urology, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, Hebei, China;
    2. Department of Pharmacy, North China Petroleum Administration Bureau General Hospital, Renqiu 062552, Hebei, China;
    3. Department of Minimally Invasive Urology Center, Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2015-05-25 Online:2015-09-10 Published:2015-09-10
  • Contact: 金讯波。E-mail:16365451@qq.com E-mail:16365451@qq.com

Abstract: Objective To evaluate significance of thymidine kinase 1 (TK1) detection in the diagnosis of malignant tumors in Chinese patients. Methods Clinical trials on TK1 detection published during Jan. 2008 to Mar 2015 were searched in databases of CNKI and Wan Fang. Revman 5.2 and Meta Disc 1.4 were used to perform the Meta-analysis.Results A total of 415 relevant articles were retrieved and 45 trials with 2,976 cancer patients (all diagnosed by the gold standard) were involved. Meta-analyses showed that the heterogeneity among studies was high, and the pooled Results suggested a moderate diagnostic efficacy. The sensitivities for lung cancer, breast cancer, gynecological cancer, prostatic cancer, gastric cancer, intestinal cancer and esophagus cancer were 0.508, 0.638, 0.524, 0.656, 0.583, 0.546, and 0.681, respectively. The specificities were 0.973, 0.932, 0.940, 0.925, 0.941, 0.947, and 0.967. Conclusion TK1 detection may have certain value in the early diagnosis and screening of malignant cancers, but it can not be serveed as an independent reference test. More high quality trials are required to confirm the significance of TK1 detection.

Key words: Thymidine kinase 1, Cancer, Specificity, Meta-analysis, Sensitivity

CLC Number: 

  • R730.4
[1] Aufderklamm S, Todenhöfer T, Gakis G, et al. Thymidine kinase and cancer monitoring[J]. Cancer Letters, 2012, 316(1):6-10.
[2] Chen YL, Eriksson S, Chang ZF. Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage[J]. J Biol Chem, 2010, 285(35):27327-27335.
[3] Xu Y, Shi QL, Ma H, et al. High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma[J]. Tumour Biol, 2012, 33(2):475-483.
[4] Stalhandske P, Wang L, Westberg S, et al. Homogeneous assay for realtime and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities[J]. Anal Biochem, 2013, 432(2):155-164.
[5] Xiang Y, Zeng H, Liu X, et al. Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis[J]. Biomed Rep, 2013, 1(4):629-637.
[6] 刘鹏飞, 姬舒荣.血清胸苷激酶1在恶性肿瘤筛查和复发转移监测中研究进展[J].中华临床医师杂志:电子版, 2013, 7(23):10858-10860. LIU Pengfei, JI Shurong. Progress advances on serum thymidine kinase 1 in screening and monitoring of malignant tumor recurrence and metastasis[J/CD]. Chin J Clinicians (Electronic Edition), 2013, 7(23):10858-10860.
[7] Chen YL, Eriksson S, Chang ZF. Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage[J]. J Biol Chem, 2010, 285(35):27327-27335.
[8] Zhou J, He E, Skog S. The proliferation marker thymidine kinase 1 in clinical use[J]. Mol Clin Oncol, 2013, 1(1):18-28.
[9] Nisman B, Allweis T, Kaduri L, et al. Serum thymidine kinase 1 activity in breast cancer[J]. Cancer Biomark, 2010, 7(2):65-72.
[10] He E, Xu XH, Guan H, et al. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma[J]. Nucleosides Nucleotides Nucleic Acids, 2010, 29(4-6):352-358.
[11] Wu BJ, Li WP, Qian C, et al. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma[J]. Tumour Biol, 2013, 34(2):643-648.
[12] 邹雄. 胸苷激酶1是恶性肿瘤预后判断的动态标志[J]. 实用检验医师杂志, 2013, 5(2):67-71. ZOU Xiong. Serum thymidine kinase 1 activity is a dynamic marker of the prognosis of malignant tumor[J]. Chinese Journal of Laboratory Pathologist, 2013, 5(2):67-71.
[13] 郭丽香, 刘树业. 胸苷激酶1—新型的细胞增殖动力学标志[J].哈尔滨医药, 2014(5):316-317. GUO Liuxiang, LIU Shuye. Thymidine kinase 1-a new cell proliferation marker[J]. Harbin Medical Journal, 2014(5):316-317.
[14] 徐文静, 刘德干. 血清胸苷激酶1与肿瘤[J]. 国际肿瘤学杂志, 2013, 40(9):643-645. XU Wenjing, LIU Degan. Serum thymidine kinase 1 and cancer[J]. Journal of International Oncology, 2013, 40(9):643-645.
[15] Chen G, He C, Li L, et al. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix[J]. BMC Cancer, 2013, 13:249. doi: 10.1186/1471-2407-13-249.
[16] Chen Y, YingM, Chen Y, et al. Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings[J]. Int J Clin Oncol, 2010, 15(4):359-368.
[17] Xu Y, Liu B, Shi QL, et al. Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung[J]. Int J Clin Exp Med, 2014, 7(8):2120-2128.
[18] Chen ZH, Huang SQ, Wang Y, et al. Serological thymidine kinase 1 is a biomarker for early detection of tumors-A health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay[J]. Sensors, 2011, 11(12):11064-11080.
[19] Bolayirli M, Papila C, Korkmaz GG, et al. Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy[J]. J Clin Lab Anal, 2013, 27(3):220-226.
[20] Chen F, Tang L, Xia T, et al. Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer[J]. Mol Clin Oncol, 2013, 1(5):894-902.
[21] Huang ZH, Tian XS, Li R, et al. Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer[J]. Exp Ther Med, 2012, 3(2):331-335.
[1] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46.
[2] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47-52.
[3] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67-71.
[4] LYU Longfei, LI Lin, LI Shuhai, QI Lei, LU Ming, CHENG Chuanle, TIAN Hui. Application of laparoscopic fine needle catheter jejunostomy in minimally invasive McKeown resection of esophageal cancer [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 77-81.
[5] DONG Wei, XING Naidong, LÜ Jiaju, LIU Shuai, SUN Liang, CAO Qingwei, DONG Yuhao, LIU Zhao, DING Sentai. The therapeutic efficacy of a potent KSP inhibitor S(MeO)TLC against docetaxel-resistant prostate cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 23-30.
[6] DI Xuemin, NIU Shulei, ZHAO Jing, DU Sui, YU Huimin, ZHANG Hongtao, WANG Juan. CT-guided 125I seed implantation for lymph node metastases in patients with gastric cancer of later stage [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 79-84.
[7] LI Xingkai, LIU Zhanye, JIANG Yunfeng, LI Jun. Clinicopathological factors and prognosis between primary central and peripheral lung squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 73-78.
[8] LIN Pingzhen, XUE Jiaomei, YANG Bei, LI Meng, ZHOU Mailin, CAO Fenglin. Correlation between posttraumatic growth and psychological adjustment of cancer survivors based on Pearson correlation coefficient: a Meta-analysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 110-121.
[9] YIN Lei, YIN Rui, LI Wenjia, LIU Shuai, L(¨overU)Jiaju. CYLD improves bladder cancer gemcitabine chemosensitivity via suppressing autophagy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 1-6.
[10] ZHANG Wenxue, XU Lidong, ZHANG Mingming, GUO Chuanguo, ZUO Xiuli. NR2B contributes to visceral hypersensitivity in irritable bowel syndrome via mBDNF [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 17-22.
[11] HAN Fuyan, CHENG Shiqing, WANG Zhaobao, JU Ying. Clinical significance of preoperative red blood cell distribution width in peripheral blood of patients with esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 67-72.
[12] ZONG Shuai, XIAO Dongjie, LIU Hua, JIA Yanfei, MA Xiaoli, LI Huanjie, LI Ping, ZHENG Yan, WANG Yunshan. Expression of CSN5 and its correlation with the prognosis of gastric carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 12-16.
[13] ZHENG Jin, ZHANG Jiangwei, WANG Xuzhen, KUANG Peidan, HE Xiaoli, XUE Wujun. Significance of lymphocytes and DSA monitoring for acute rejection diagnosis on the early stage of kidney transplantation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 89-94.
[14] ZENG Haiyan, LI Rui, SUN Xindong, XIE Peng, MENG Xue, FAN Bingjie, LI Wanlong, YUAN Shuanghu. Association analysis of brain metastases after prophylactic cranial irradiation in local disease small cell lung cancer: a bicenter study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 61-66.
[15] LI Yanxiang, ZHANG Wenhua, YANG Feilong, FANG Liang, XU Zhonghua. The correlation between BRCA1 mRNA and protein expressions in epithelial urethra cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 91-94.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!